Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cystic fibrosis
cystic fibrosis
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Business Insider
Fri, 06/26/20 - 07:47 pm
Vertex Pharmaceuticals
Europe
EMA
CHMP
cystic fibrosis
Kalydeco
Kaftrio
Vertex's cystic fibrosis drugs work, but they're too expensive, ICER finds
Endpoints
Tue, 04/28/20 - 10:56 am
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
ICER
Arrowhead Pharmaceuticals files for regulatory clearance to begin phase 1/2a study of ARO-ENaC for treatment of cystic fibrosis
Pharmaceutical Business Review
Mon, 04/13/20 - 10:50 am
Arrowhead Pharmaceuticals
clinical trials
cystic fibrosis
ARO-ENaC
RNAi
Coupling mRNA with tRNA and new delivery tech, MPM and OrbiMed help birth new $80M biotech into a slowed down world
Endpoints
Thu, 03/26/20 - 10:31 am
MPM
OrbiMed
TranscripTx
ReCode Therapeutics
cystic fibrosis
MRNA
tRNA
Eloxx cuts staff, CEO and shakes up leadership team
Fierce Biotech
Thu, 02/27/20 - 10:33 am
Eloxx Pharmaceuticals
layoffs
cystic fibrosis
What's in Store for Vertex in 2020 After a Remarkable 2019?
Yahoo/Zacks.com
Sat, 02/15/20 - 02:05 pm
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Symdeko
Trikafta
Vertex impresses with strong Trikafta launch
BioPharma Dive
Thu, 01/30/20 - 09:26 pm
Vertex Pharmaceuticals
drug launches
cystic fibrosis
Trikafta
earnings
Novel Drug Candidate Aims To Tackle Superbug Infections In Cystic Fibrosis Patients
Forbes
Sat, 01/18/20 - 04:57 pm
cystic fibrosis
Antabio
superbugs
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Mon, 01/13/20 - 11:53 pm
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
BioCentury
Tue, 11/5/19 - 10:20 am
Vertex Pharmaceuticals
FDA
cystic fibrosis
Trikafta
Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie
BioSpace
Thu, 10/24/19 - 05:44 pm
AbbVie
cystic fibrosis
drug development
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
Stat
Thu, 10/24/19 - 10:31 am
Vertex Pharmaceuticals
cystic fibrosis
UK
‘A game-changer’: How Vertex delivered on cystic fibrosis
Stat
Wed, 10/23/19 - 10:33 pm
Vertex Pharmaceuticals
cystic fibrosis
Trikafta
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
Stat
Mon, 10/21/19 - 04:33 pm
Vertex Pharmaceuticals
cystic fibrosis
FDA
Trikafta
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Motley Fool
Tue, 10/8/19 - 10:21 am
Vertex Pharmaceuticals
cystic fibrosis
gene editing
Vertex deal for Scotland — no deal for England
Endpoints
Fri, 09/13/19 - 10:22 am
Vertex Pharmaceuticals
cystic fibrosis
Scotland
England
UK
Symkevi
Orkambi
Vertex sinks on reports of patient deaths tied to cystic fibrosis drug
Stat
Wed, 08/28/19 - 12:41 pm
Vertex Pharmaceuticals
cystic fibrosis
patient deaths
Symdeko
FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
Endpoints
Tue, 08/20/19 - 12:43 pm
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
tezacaftor/ivacaftor
What happened a year ago this week in biopharma? August 12-18, 2018
Mon, 08/19/19 - 11:04 am
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »